A. Ribeiro-de-oliveira et al., Bromocriptine-induced dissociation of hyperglycemia and prolactin responseto restraint, PHARM BIO B, 68(2), 2001, pp. 229-233
The present study investigated the effects of immobilization (restraint str
ess) on rat chronically treated with a D-2 receptor agonist (bromocriptine,
0.4 mg/100 g body weight, injected daily intraperitoneally (ip) for 2 week
s) on plasma glucose, prolactin, and insulin levels. During restraint, the
plasma prolactin of vehicle-treated (VEH) rats increased rapidly, reaching
a peak at 10 min (57.9 +/- 8.1 ng/ml, P<.01). In contrast, restraint failed
to induce any significant change in the plasma prolactin levels of bromocr
iptine-treated (BR) rats. The hyperglycemic response to immobilization was
97% higher (P<.05) in BR rats than in VEH rats. Our data demonstrate that p
rolactin secretion and hyperglycemia in response to restraint can be dissoc
iated by chronic treatment with BR, which also increased the hyperglycemic
response to immobilization probably due to central D-2 dopaminergic activit
y. (C) 2001 Elsevier Science Inc. All rights reserved.